← Eichor
Condition: High Grade Astrocytic Tumor Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: High Grade Astrocytic Tumor

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma
Phase 1 · 1 location(s) · Beijing Biotech · NCT074809415G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours
Phase 1/Phase 2 · 3 location(s) · Institute of Cancer Research, United Kingdom · NCT066302605G-PEARL: Paxalisib in Malignant Brain Tumours
Phase 1/Phase 2 · 1 location(s) · Institute of Cancer Research, United Kingdom · NCT07391215Venous Thromboembolism Prevention in Outpatients With Glioma
Phase 2 · 1 location(s) · University of Vermont Medical Center · NCT05683808Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
Phase 1/Phase 2 · 1 location(s) · Emory University · NCT04590664A Study of 177Lu-PSMA-617 in People With Gliomas
Phase 1 · 7 location(s) · Memorial Sloan Kettering Cancer Center · NCT07223034Adenovirus Mediated Suicide Gene Therapy With Radiotherapy in Progressive Astrocytoma.
Phase 1 · 1 location(s) · Henry Ford Health System · NCT05686798Safety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL Treatment
Phase 1 · 1 location(s) · Plus Therapeutics · NCT05460507ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
Phase 1 · 1 location(s) · Mayo Clinic · NCT05917145Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
Phase 1/Phase 2 · 1 location(s) · Mayo Clinic · NCT07468136The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06146725LITT Followed by Hypofractionated RT for Newly Diagnosed Gliomas (GCC 20138)
NA · 5 location(s) · University of Maryland, Baltimore · NCT04699773Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Di
Phase 1 · 20 location(s) · Children's Oncology Group · NCT06894979Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progress
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT06815029Study of Olutasidenib and Temozolomide in HGG
Phase 2 · 20 location(s) · Rigel Pharmaceuticals · NCT06161974Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
NA · 1 location(s) · Northwell Health · NCT05954858Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)
NA · 2 location(s) · Medical University of Warsaw · NCT07488754PET-Guided Resection in High-Grade Gliomas
Phase N/A · 2 location(s) · Universita degli Studi di Genova · NCT07567196The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06146738IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
Phase 1 · 1 location(s) · University of Florida · NCT05353530Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
Phase 2 · 1 location(s) · Mayo Clinic · NCT05465954Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
Phase 1 · 1 location(s) · Case Comprehensive Cancer Center · NCT05565118A Study of Temodar With Abexinostat (PCI-24781) for Patients With Recurrent Glioma
Phase 1 · 1 location(s) · University of Nebraska · NCT05698524Targeted Pediatric High-Grade Glioma Therapy
Phase N/A · 21 location(s) · Nationwide Children's Hospital · NCT05839379DB107-Retroviral Replicating Vector (RRV) Combined With DB107-Flucytosine (FC) in Patients With Recurrent Glioblastoma o
Phase 2 · 1 location(s) · Ashish Shah · NCT06264388GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma an
Phase 2 · 1 location(s) · Mayo Clinic · NCT07301268Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
Phase 2 · 1 location(s) · Marzieh Ebrahimi · NCT06687681Characterization of the Blood-Brain Barrier in High-Grade Glioma Through Immunohistochemical, Transcriptional, Fluoresce
NA · 1 location(s) · Patrick Morris · NCT07731555Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07410494Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
NA · 1 location(s) · Northwell Health · NCT05979064
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.